Articles tagged with Enzymes
Researchers at the University of Washington developed GlucoScreen, a new system that leverages smartphone capacitive touch sensing to measure blood glucose levels. The system's accuracy is comparable to standard glucometer testing, making it potentially less costly and more accessible for widespread screening.
A new AI tool, CLEAN, can predict enzyme functions based on amino acid sequences, outperforming leading state-of-the-art tools in accuracy and reliability. The tool was developed using contrastive learning and verified experimentally with both computational and in vitro experiments.
A team of scientists has designed a molecule that targets the PLpro enzyme in SARS-CoV-2, limiting its replication and hampering the host's immune response. The covalent inhibitor shows promise as a new treatment for COVID-19 and other viral diseases.
Researchers at Oregon State University have created a portable sensor that can detect cortisol hormone levels in sweat, providing a fast and reliable diagnostic tool for various diseases. The device uses an artificial enzyme to capture cortisol molecules, producing electrical signals that indicate the hormone's presence.
A study by IMBA researchers links muscle degeneration to a deficiency in the enzyme PCYT2, essential for lipid synthesis. PCYT2 depletion affects mitochondrial function and muscle energetics, highlighting the importance of lipid balance in muscle health.
Researchers at NTU Singapore have found a way to spur brain immune cells to clear toxic waste linked to Alzheimer’s disease by targeting their metabolism. The study reveals a ‘metabolic switch’ in the brain’s immune cells that can be manipulated to improve their function.
The study reveals that enzyme ATE1 enhances activity upon binding iron-sulfur clusters and is sensitive to oxygen, moderating the cell's response to oxidative stress. This discovery could lead to new therapeutic targets for diseases tied to chronic cellular stress.
Researchers at Kyoto University found that neutrophils instruct macrophages to form a bacteria-permissive microenvironment, which could have implications for cancer treatment. The study suggests that A9, an enzyme expressed in neutrophils, may play a key role in this process.
Researchers at the University of Virginia have identified a promising approach to delay aging by detoxifying glycerol and glyceraldehyde, harmful by-products of fat. By activating an enzyme called AMAR, they found that microscopic worms lived longer and healthier lives, and similar effects were seen in other lab models.
Researchers found that Fumarate Hydratase is repressed in macrophages, leading to the release of cytokines and worsening inflammation. Restoring or targeting this enzyme could lead to new anti-inflammatory therapies for diseases like Lupus and sepsis.
A hormone called FGF21 protects mice from ethanol-induced loss of balance and righting reflex by activating a specific part of the brain that controls alertness. The study reveals that higher FGF21 concentrations can dramatically accelerate recovery from intoxication.
A study by Kumamoto University researchers reveals LSD1's role in regulating skeletal muscle response to environmental stress. The findings suggest that LSD1 moderates muscle adaptation to environmental conditions, with potential implications for maintaining muscle health and preventing diseases such as sarcopenia.
The University of Houston researchers have developed a new test that uses glow-in-the-dark materials to improve the sensitivity and accuracy of at-home COVID-19 tests. The test, which can detect COVID-19 proteins more efficiently, has shown excellent results compared to commercial tests.
Soil bacteria have been used to produce prodrugs by selectively epoxidating indole and indene. This breakthrough enables the sustainable biocatalysis of active pharmaceutical ingredients with high purity.
Researchers at Rockefeller University have found queen-like mutants among social parasite ants, which can infiltrate and take over host colonies. These unique ants exhibit intermediate traits between worker and queen behavior, allowing them to thrive in the colony while avoiding dangers associated with leaving their nest.
Researchers at Aarhus University have found an enzyme, C-P lyase, in E. coli bacteria that can degrade highly stable chemicals, including pesticides like RoundUp. The enzyme uses energy from ATP to open and close a 'nutcracker' mechanism that traps and breaks down troublesome chemicals.
Research by the University of the Basque Country found that gluten-free products often lack essential nutrients like fibre and protein. Gluten-free pasta, for example, is now made from millet instead of rice flour, improving nutrition.
Researchers have discovered a surprising mechanism by which the molecular machine Dis3L2 unwinds and destroys RNA molecules. By changing shape, Dis3L2 reveals an RNA-splitting wedge, allowing it to execute its tasks in a more dynamic and versatile way.
Researchers have successfully grown electrodes in living tissue using the body's molecules as triggers, paving the way for fully integrated electronic circuits in living organisms. This breakthrough method allows for substrate-free organic bioelectronics and targets specific biological substructures for nerve stimulation.
Researchers at Washington State University found that CBD inhibits a key enzyme for nicotine metabolism, slowing down its effects and allowing smokers to wait before feeling the urge to smoke. The study suggests that CBD could be a useful tool in reducing harm from smoking and quitting nicotine addiction.
A team of scientists developed a simplified and efficient method for artificial production of terpenes, using fluorinated alcohol catalyst solutions. This approach allows targeted production of natural substances from simple starting materials, offering potential applications in food, cosmetics, and pharmaceutical industries.
A new study found that a medication previously used to treat seizures can reprogram donor hearts to boost the production of beneficial enzymes, increasing storage time and improving post-transplant function. This technology could lead to a paradigm shift in extending heart storage and reducing primary graft dysfunction.
Scientists at Sanford Burnham Prebys have discovered a new treatment approach that can kill prostate cancer cells by targeting the PI5P4Kα enzyme. This finding has significant implications for addressing treatment resistance in prostate cancer and may lead to improved treatments for other cancers.
Researchers discovered that mitochondria actively transport coenzyme Q to the cell surface to protect cells from cell death. The transport process is crucial for regulating coenzyme Q distribution within the cell.
Researchers have discovered a way to produce limonoids, a family of valuable chemicals with potential as bee-friendly insecticides and anti-cancer drugs. By identifying the enzymes required for production, they can now use host organisms to create these compounds in a more sustainable way.
Rice University scientists identified a new Diels-Alderase enzyme, CtdP, which catalyzes the Diels-Alder reaction with precise stereochemistry control. This discovery could lead to improved pharmaceutical synthesis and development of more effective drugs.
Researchers at the Max Planck Institute for Marine Microbiology reveal how a specific enzyme, Fsr, converts sulfite into sulfide, allowing methanogens to grow safely on toxic substances. This discovery opens opportunities for biotechnological applications and provides insights into the evolution of these microorganisms.
Researchers found that an algal strain with a defective Old Yellow Enzyme biocatalyst exhibits oxidative damage due to insufficient light energy dissipation. The study suggests that the enzyme plays a crucial role in maintaining photosynthetic balance.
Researchers from KAIST and Chungnam National University have developed a new equation to predict drug interactions, improving accuracy by 80% compared to the existing FDA formula. The new equation takes into account factors such as gut bioavailability and enzyme concentration.
Researchers from ETH Zurich elucidated the structure and function of tryptophan C-mannosyltransferase (CMT), a glycosyltransferase enzyme involved in C-mannosylation. The study reveals the enzyme's novel mechanism, enabling precise understanding of protein sequences and sugar substrates.
Researchers found that abnormal methylation processes lead to disruption of gene expression essential for brain development in people with Williams syndrome. The study suggests targeting treatments to correct these disruptions.
Researchers have improved the FDA's equation for predicting drug interactions by addressing fundamental limitations and incorporating new models. The modified equation has shown a significantly increased accuracy of about 80%, which is expected to contribute to increasing the success rate of new drug development.
Researchers at La Jolla Institute for Immunology have discovered that OGT regulates mTOR, a key protein for mitochondrial powerhouses, keeping cells healthy. The study may lead to important medical advances in understanding cancers, diabetes, and cardiovascular disease.
Plant biochemists have discovered a new level of regulation in the biochemical machinery that plants use to convert organic carbon into aromatic compounds. The research reveals new strategies for controlling plant biochemistry, including genetic tools to precisely control which compounds get produced in different parts of a plant.
Researchers discovered that methanotroph Methylococcus capsulatus Bath can grow in the presence of small amounts of H2S using an enzyme switch. The study found that at 0.75% H2S concentration, bacteria switch from mxaF to xoxF, increasing methane consumption and mitigating greenhouse effects.
Researchers at EMBL Grenoble have discovered that THC inhibits the human enzyme autotaxin, which is involved in cancer, inflammation, and pulmonary fibrosis. This finding provides new molecular insights into the therapeutic effects of medical cannabis.
Researchers at Rice University have developed a photochemical process that simplifies the manufacture of essential precursors for drugs and agricultural chemicals. By illuminating reagents with visible light, they can form diazides in conditions far gentler than current industrial processes.
A recent study found that the APOBEC3G enzyme can cause numerous mutations in bladder tumor cells, leading to increased malignancy and mortality. The research suggests that this enzyme could be a potential target for cancer treatment strategies.
Researchers found a new role for enzymes regulating genome function, which is linked to diseases such as brain tumors, blood cancers, and Kleefstra syndrome. The discovery could help understand these diseases and develop new treatments.
Researchers analyzed COX-2 levels and segmental chromosome aberrations in pediatric neuroblastoma tumor samples. Positive correlations between pre-CT Ch 7q gain and COX-2 expression were found, as well as negative correlations between Ch 7q gain and Ch 11q deletion.
In a groundbreaking study, researchers at Eötvös Loránd University have found that gland cells in Drosophila melanogaster can remove defective secretory particles as early as the secretion process begins. This discovery sheds new light on crinophagy, a previously understudied process crucial for maintaining cellular quality and function.
A global study reveals that antimicrobial resistance genes in bacteria are driven by various factors, including geographic regions and hosts. The research identifies key genes conferring resistance to critically important drugs, shedding light on the mechanisms of transmission and the need for collaborative interventions.
Researchers at Johns Hopkins Medicine discovered that regulating the electrical charge on the inner side of the cell membrane can activate pathways responsible for cell movement. This finding has potential implications for understanding cancer cell migration and immune cell function.
A University of Ottawa-led team identified a new entry route for SARS-CoV-2 using metalloproteinases, which may lead to more widespread cell infection and severe illness. The study suggests that variants like the Delta strain may prefer this entry method, while others like Omicron do not.
Researchers from University of Cologne and Technical University of Munich discovered that the signal peptidase complex plays a crucial role in quality control of membrane proteins. The complex cleaves faulty membrane proteins to initiate their degradation, maintaining cellular function. This discovery has important implications for und...
A team of scientists, led by Marco Fraaije from the University of Groningen, has developed an enzyme that can convert lignin monomers into useful chemical building blocks. The enzyme has been engineered to be stable, selective, and faster in conversion, offering a promising solution for the valorization of biomass.
Researchers found an imbalance in an important immune system signaling pathway associated with severe COVID-19. They detected dysregulation of the immune system mediated by ATP, leading to a pro-inflammatory state and potentially fatal systemic inflammation.
University of Copenhagen researchers made a groundbreaking discovery about the mammalian brain, finding that a vital enzyme that enables brain signals is switching on and off at random intervals. This challenges the long-held assumption that these enzymes are active at all times to convey essential signals continuously.
Researchers discovered how enzymes metabolize chiral PCBs, leading to neurodevelopmental issues. The study found that mirror-image isomers are metabolized differently, causing selective toxicity in humans and animals.
Researchers at Max-Planck Institute for Terrestrial Microbiology have deciphered the biosynthesis of benzobactins, a class of natural compounds with special biological activity. The study reveals that these compounds are widespread in diverse bacteria and could be excellent candidates for future drug therapy.
Albert Almada's laboratory will explore the role of Nicotinamide Adenine Dinucleotide (NAD+) in muscle repair and regeneration. Lower levels of NAD+ may be inactivating stem cell repair, and re-activating it could promote better muscle healing in older animals.
Researchers at Cambridge University have successfully created artificial enzymes, known as XNAzymes, that can target and destroy the genetic code of SARS-CoV-2, a promising approach to develop new antiviral drugs. The engineered enzymes are highly specific and can be programmed to attack mutated RNAs involved in cancer or other diseases.
A team of researchers from Martin-Luther-University Halle-Wittenberg has discovered a transport pathway for manganese in plants and the role that BICAT3 plays in this process. The protein is responsible for transporting manganese to where it needs to go in plant cells, leading to improved crop growth.
The West Texas Pharmacology Core laboratory at TTUHSC will focus on two primary areas: drug development and pediatric cancer. The core aims to address obstacles in drug development, including limited pharmacology expertise for small biotech companies and low profitability for pediatric cancer drugs.
A fetus with infantile-onset Pompe disease has been successfully treated in utero using enzyme replacement therapy, resulting in normal cardiac and motor function. The child is now thriving as a toddler, meeting developmental milestones after receiving postnatal enzyme therapy at a pediatric hospital.
Researchers discovered Fyn enzyme clusters when immobilized in synapses, forming toxic 'protein clumps' linked to dementia. Targeting Tau biomolecular condensates may prevent dementia progression.
The research reveals PAPP-A's heart-shaped structure and its interaction with STC2, a key regulator of IGF conversion. The study suggests that complex formation between PAPP-A and STC2 is highly regulated, influencing height by up to 2.1 cm.
Researchers from Johannes Gutenberg University Mainz developed ceria nanoparticles to silence bacteria by modifying signaling molecules, preventing biofilm formation. This approach mimics nature's defense system and has potential for creating antibacterial surfaces without resistance.
Researchers at Kyoto University have developed a prodrug form of curcumin called TBP1901, which has shown anti-tumor effects without causing harm. The study found that TBP1901's conversion to active curcumin is dependent on the enzyme GUSB, suggesting its potential therapeutic targets.
Scientists have developed an enzyme that effectively breaks down signaling molecules used by bacteria to produce biofilms. The enzyme, LrsL, has exceptional efficacy in suppressing biofilm formation by Pseudomonas aeruginosa, a bacterium known for causing hospital-acquired infections.